Creo Medical Group (CREO) Competitors GBX 16.69 -0.06 (-0.36%) (As of 06:11 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades CREO vs. EKF, IUG, NCYT, POLX, BELL, IHC, AVO, RUA, MHC, and SUNShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Belluscura (BELL), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), and Surgical Innovations Group (SUN). These companies are all part of the "medical devices" industry. Creo Medical Group vs. EKF Diagnostics Intelligent Ultrasound Group Novacyt Polarean Imaging Belluscura Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Surgical Innovations Group Creo Medical Group (LON:CREO) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation. Which has better earnings and valuation, CREO or EKF? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreo Medical Group£30.30M2.00-£22.40M-£0.06-279.17EKF Diagnostics£50.95M2.31£4.78M£0.012,595.00 Which has more volatility & risk, CREO or EKF? Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Does the MarketBeat Community prefer CREO or EKF? EKF Diagnostics received 221 more outperform votes than Creo Medical Group when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote. CompanyUnderperformOutperformCreo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% EKF DiagnosticsOutperform Votes32776.76% Underperform Votes9923.24% Do insiders & institutionals believe in CREO or EKF? 56.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 70.3% of EKF Diagnostics shares are held by institutional investors. 22.4% of Creo Medical Group shares are held by company insiders. Comparatively, 5.2% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor CREO or EKF? In the previous week, EKF Diagnostics had 1 more articles in the media than Creo Medical Group. MarketBeat recorded 1 mentions for EKF Diagnostics and 0 mentions for Creo Medical Group. EKF Diagnostics' average media sentiment score of 1.05 beat Creo Medical Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Creo Medical Group Neutral EKF Diagnostics Positive Is CREO or EKF more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.58% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Creo Medical Group-73.93% -38.49% -20.09% EKF Diagnostics 9.37%7.58%5.27% SummaryEKF Diagnostics beats Creo Medical Group on 13 of the 15 factors compared between the two stocks. Ad Brownstone ResearchBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£60.60M£1.98B£5.00B£1.19BDividend YieldN/A2.49%7.77%11.67%P/E Ratio-283.33197.6489.801,609.33Price / Sales2.00203.211,290.59244,934.52Price / Cash2.4316.4933.7033.79Price / Book1.293.424.672.78Net Income-£22.40M£68.88M£116.13M£153.51M7 Day Performance-7.10%-0.89%-2.96%4.53%1 Month Performance-17.28%5.41%-3.98%3.06%1 Year Performance-48.85%22.61%30.67%133.44% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 16.69-0.4%N/A-48.1%£60.38M£30.30M-278.17279EKFEKF DiagnosticsN/AGBX 26.11+0.6%N/A-7.9%£118.46M£50.95M2,610.80356Positive NewsGap DownIUGIntelligent Ultrasound GroupN/AGBX 11.80+2.6%N/A+17.9%£38.59M£9.88M-1,180.0065Gap UpNCYTNovacytN/AGBX 48-3.4%N/A-5.7%£33.90M£18.56M-92.31120POLXPolarean ImagingN/AGBX 1.55flatN/A-77.2%£18.76M£1.87M-77.5028BELLBelluscuraN/AGBX 9.58-4.3%N/A-58.8%£16.13M£1.80M-95.7524Gap DownIHCInspiration Healthcare GroupN/AGBX 15.75flatN/A-61.3%£14.12M£34.30M-112.50224Positive NewsGap DownAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.03-2.0%N/A-29.4%£6.84M£2.19M-275.6348MHCMyHealthCheckedN/AGBX 12.13-3.0%N/A+14.3%£6.31M£9.39M-606.5016Gap DownSUNSurgical Innovations GroupN/AGBX 0.55flatN/AN/A£5.13M£12.54M-21.1180Gap Down Related Companies and Tools Related Companies EKF Diagnostics Competitors Intelligent Ultrasound Group Competitors Novacyt Competitors Polarean Imaging Competitors Belluscura Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors MyHealthChecked Competitors Surgical Innovations Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CREO) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CREO Stock Alerts